Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk


Blood pressure is a heritable trait1 influenced by several biological pathways and responsive to environmental stimuli. Over one billion people worldwide have hypertension (≥140 mm Hg systolic blood pressure or ≥90 mm Hg diastolic blood pressure)2. Even small increments in blood pressure are associated with an increased risk of cardiovascular events3. This genome-wide association study of systolic and diastolic blood pressure, which used a multi-stage design in 200,000 individuals of European descent, identified sixteen novel loci: six of these loci contain genes previously known or suspected to regulate blood pressure (GUCY1A3GUCY1B3, NPR3C5orf23, ADM, FURINFES, GOSR2, GNASEDN3); the other ten provide new clues to blood pressure physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function. We also observed associations with blood pressure in East Asian, South Asian and African ancestry individuals. Our findings provide new insights into the genetics and biology of blood pressure, and suggest potential novel therapeutic pathways for cardiovascular disease prevention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Genome-wide −log 10 P -value plots and effects for significant loci.

Similar content being viewed by others


  1. Levy, D. et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension 36, 477–483 (2000)

    Article  CAS  Google Scholar 

  2. Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217–223 (2005)

    Article  Google Scholar 

  3. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002)

  4. Lifton, R. P., Gharavi, A. G. & Geller, D. S. Molecular mechanisms of human hypertension. Cell 104, 545–556 (2001)

    Article  CAS  Google Scholar 

  5. Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nature Genet. 41, 666–676 (2009)

    Article  CAS  Google Scholar 

  6. Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nature Genet. 41, 677–687 (2009)

    Article  CAS  Google Scholar 

  7. Meyer, T. E. et al. GOSR2 Lys67Arg is associated with hypertension in whites. Am. J. Hypertens. 22, 163–168 (2009)

    Article  CAS  Google Scholar 

  8. Li, N. et al. Associations between genetic variations in the FURIN gene and hypertension. BMC Med. Genet. 11, 124 (2010)

    Article  CAS  Google Scholar 

  9. Mussig, K. et al. 17α-hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 gene. J. Clin. Endocrinol. Metab. 90, 4362–4365 (2005)

    Article  Google Scholar 

  10. Ridker, P. M. et al. Rationale, design, and methodology of the Women’s Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin. Chem. 54, 249–255 (2008)

    Article  CAS  Google Scholar 

  11. Burt, V. L. et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26, 60–69 (1995)

    Article  CAS  Google Scholar 

  12. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. Br. Med. J. 336, 1121–1123 (2008)

  13. Law, M. R., Morris, J. K. & Wald, N. J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Br. Med. J. 338, b1665 (2009)

    Article  CAS  Google Scholar 

  14. Lewis, J. B. Blood pressure control in chronic kidney disease: is less really more? J. Am. Soc. Nephrol. 21, 1086–1092 (2010)

    Article  Google Scholar 

  15. Park, J. H. et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nature Genet. 42, 570–575 (2010)

    Article  CAS  Google Scholar 

  16. Newton-Cheh, C. et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nature Genet. 41, 348–353 (2009)

    Article  CAS  Google Scholar 

  17. Schenk, D. B. et al. Purification and subunit composition of atrial natriuretic peptide receptor. Proc. Natl Acad. Sci. USA 84, 1521–1525 (1987)

    Article  CAS  ADS  Google Scholar 

  18. Schmidt, H. H. & Walter, U. NO at work. Cell 78, 919–925 (1994)

    Article  CAS  Google Scholar 

  19. Matsukawa, N. et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl Acad. Sci. USA 96, 7403–7408 (1999)

    Article  CAS  ADS  Google Scholar 

  20. Friebe, A., Mergia, E., Dangel, O., Lange, A. & Koesling, D. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc. Natl Acad. Sci. USA 104, 7699–7704 (2007)

    Article  CAS  ADS  Google Scholar 

  21. Ishimitsu, T., Ono, H., Minami, J. & Matsuoka, H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol. Ther. 111, 909–927 (2006)

    Article  CAS  Google Scholar 

  22. Pushkin, A. et al. Cloning, tissue distribution, genomic organization, and functional characterization of NBC3, a new member of the sodium bicarbonate cotransporter family. J. Biol. Chem. 274, 16569–16575 (1999)

    Article  CAS  Google Scholar 

  23. Hinkes, B. et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nature Genet. 38, 1397–1405 (2006)

    Article  CAS  Google Scholar 

  24. Feder, J. N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13, 399–408 (1996)

    Article  CAS  Google Scholar 

  25. He, L., Wang, B., Hay, E. B. & Nebert, D. W. Discovery of ZIP transporters that participate in cadmium damage to testis and kidney. Toxicol. Appl. Pharmacol. 238, 250–257 (2009)

    Article  CAS  Google Scholar 

  26. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010)

    Article  CAS  ADS  Google Scholar 

  27. Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genet. 42, 937–948 (2010)

    Article  CAS  Google Scholar 

  28. Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nature Genet. 43, 531–538 (2011)

    Article  CAS  Google Scholar 

Download references


A number of the participating studies and authors are members of the CHARGE and Global BPgen consortia. Many funding mechanisms by NIH/NHLBI, European and private funding agencies contributed to this work and a full list is provided in section 21 of the Supplementary Materials.

Author information

Authors and Affiliations



Full author contributions and roles are listed in Supplementary Materials section 19.

Corresponding authors

Correspondence to Patricia B. Munroe, Aravinda Chakravarti, Christopher Newton-Cheh, Daniel Levy or Mark J. Caulfield.

Ethics declarations

Competing interests

The author declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Text, legends for Supplementary Tables 1-14 (see separate file Supplementary Tables file (“ICBPresub4_SoMtables_final.xls”), Supplementary Table 15, Supplementary Figures 1-6 with legends, Supplementary Reference, Author Contributions and Acknowledgements (see Contents for more details). (PDF 13542 kb)

Supplementary Tables

This file (“ICBPresub4_SoMtables_final.xls”) contains Supplementary Tables 1-14 (see Supplementary Information files for legends). (XLS 234 kb)

Supplementary Data

This zipped file (“ICBP-summary-Nature.csv”) contains the genome-wide meta-analysis p-values. The definitions of the variables are as follows: rsid: SNP ID (rs number); chr.hg18: chromosome; pos.hg18: physical position in hg18 coordinates; pval.GC.SBP: genome-wide meta-analysis p-values for systolic blood pressure, corrected for genomic control; pval.GC.DBP: genome-wide meta-analysis p-values for diastolic blood pressure, corrected for genomic control. This file was replaced on 07 October 2011. Should you experience a problem opening this file please go to the following link (please choose Supplementary Materials: Data file (genome-wide pvals) - the other files are old versions). (ZIP 28365 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

The International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing